European Urology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Antimicrobial prophylaxis in robot assisted laparoscopic radical prostatectomy: A systematic review
2024
-
Assessing the long-term efficacy and safety of MV140 sublingual bacterial vaccine in the initial cohort: A 9-year study in the UK for treating recurrent urinary tract infections in men and women
2024
-
Mirabegron versus placebo and other therapeutic modalities in the treatment of patients with overactive bladder syndrome - a systematic review
2024
-
Systematic review of the incidence of and risk factors for urothelial cancers and renal cell carcinoma among patients with haematuria
2024
-
The diagnostic accuracy of cystoscopy for detecting bladder cancer in adults presenting with haematuria: A systematic review from the European Association of Urology Guidelines Office
2024
-
Understanding variation in treatment intensification for de novo metastatic Castration Sensitive Prostate Cancer (mCSPC): A population-based cohort study
2024
-
Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
2024
-
12-month outcomes from the first north american study of the zenflow spring system for the treatment of benign prostatic hyperplasia (BPH)
2023
-
Timing of symptomatic venous thromboembolism after surgery: A systematic review and meta-analysis
2023
-
Clinical significance of alpha 2,3-sialylated prostate-specific antigen density and MRI for high-grade prostate cancer in biopsy-naive men with elevated PSA level.
2022
-
Effect of 18F-DCFPyL PET/CT (=PSMA PET) on the management of patients with suspected limited residual/recurrent disease following radical prostatectomy: Results of a prospective, multicenter registry trial
2022
-
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study
2021
-
A systematic review of patients' values, preferences and expectations for the diagnosis and treatment of male Lower Urinary Tract Symptoms (LUTS)
2021
-
Antibiotic prophylaxis for prevention of infectious complications after shockwave lithotripsy: A systematic review and meta-analysis
2021
-
Benefits and harms of Botulinum Toxin-A in the treatment of chronic pelvic pain syndromes: Systematic review by the EAU Chronic Pelvic Pain Panel
2021
-
Effectiveness of interventions in patients who develop graft nephrolithiasis after kidney transplantation: A systematic review
2021
-
Efficacy and safety of the sublingual bacterial vaccine MV140 in women with recurrent urinary tract infections: An European phase III, multicentre, randomized, double-blind, placebo-controlled trial
2021
-
Lessons learned with remote research among older adults during COVID-19, a qualitative reflection
2021
-
Practice variation in the management of adult hydroceles: A multinational survey
2021
-
Surgical treatment in ischaemic and non-ischaemic priapism: A systematic review
2021
-
VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer..
87:512-523.
2025
-
European Association of Urology-European Society of Paediatric Urology Guidelines on Paediatric Urology: Summary of 2024 Updates. Part II..
S0302-2838(25)00144-7.
2025
-
Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic Review..
86:315-326.
2024
-
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study.
86:4-9.
2024
-
Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children.
85:433-442.
2024
-
A0638 Understanding variation in treatment intensification for de novo metastatic Castration Sensitive Prostate Cancer (mCSPC): A population-based cohort study.
85:s1571.
2024
-
A0846 Systematic review of the incidence of and risk factors for urothelial cancers and renal cell carcinoma among patients with haematuria.
85:s1872-s1873.
2024
-
A0848 Mirabegron versus placebo and other therapeutic modalities in the treatment of patients with overactive bladder syndrome – a systematic review.
85:s1876-s1877.
2024
-
A0858 The diagnostic accuracy of cystoscopy for detecting bladder cancer in adults presenting with haematuria: A systematic review from the European Association of Urology Guidelines Office.
85:s1892.
2024
-
Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS): An international, multicentre, randomised pragmatic trial.
85:S409-S410.
2024
-
Bladder cancer patient-derived organoids: A new frontier for personalized therapy.
85:S1909-S1910.
2024
-
Patient-derived organoids: 3D miniature models of bladder cancer.
85:S1907-S1908.
2024
-
Reply to Badar M. Mian. Prostate Biopsy: Hyperbole and Misrepresentation Versus Scientific Evidence and Equipoise. Eur Urol. 2024;85:99–100.
85:313-314.
2024
-
The role of artificial intelligence in urological cancers: An overview of systematic reviews.
85:S1880-S1880.
2024
-
Reply to Qingpeng Xie and Dianqiu Shen’s Letter to the Editor re: Bhavan P. Rai, José Luis Dominguez Escrig, Luís Vale, et al. Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria. Eur Urol 2022;82:182–92.
85:e15-e16.
2024
-
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
84:361-370.
2023
-
Optimizing Treatment Selection in Advanced Renal Cell Carcinoma via IMDC Risk Group Stratification.
84:379-380.
2023
-
Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms..
84:207-222.
2023
-
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma.
84:109-116.
2023
-
Corrigendum to “Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma” [Eur Urol 2023].
83:e166-e167.
2023
-
A1009 Timing of symptomatic venous thromboembolism after surgery: A systematic review and meta-analysis.
83:s1453-s1454.
2023
-
A1297 Benefit of whole-pelvis radiation for patients with muscle-invasive bladder cancer: An inverse probability treatment weighted analysis.
83:s1888-s1889.
2023
-
Comparing treatment outcomes for fluoroscopic and fluoroscopy-free endourological procedures: A systematic review on behalf of the EAU urolithiasis guidelines panel.
83:S1436-S1437.
2023
-
Can Oncogenic Driver Alterations be Responsible for the Lack of Immunotherapy Efficacy in First-line Advanced Urothelial Carcinoma?.
83:1-2.
2023
-
European Association of Urology Guidelines on Male Urinary Incontinence.
82:387-398.
2022
-
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.
82:182-192.
2022
-
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.
81:337-346.
2022
-
Clinical significance of α2,3-sialylated prostate-specific antigen density and MRI for high-grade prostate cancer in biopsy-naïve men with elevated PSA level..
81:S729-S731.
2022
-
Effect of 18F-DCFPyL PET/CT (=PSMA PET) on the management of patients with suspected limited residual/recurrent disease following radical prostatectomy: Results of a prospective, multicenter registry trial.
81:S299-S299.
2022
-
Adjuvant Immune Checkpoint Inhibition in Muscle-invasive Bladder Cancer: Is It Ready for Prime Time?.
80:679-681.
2021
-
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer.
80:531-545.
2021
-
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.
80:374-382.
2021
-
Re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol 2021;80:374–82.
80:e77-e78.
2021
-
Free Graft Augmentation Urethroplasty for Bulbar Urethral Strictures: Which Technique Is Best? A Systematic Review.
80:57-68.
2021
-
A Systematic Review of Patients’ Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms.
79:796-809.
2021
-
Benefits and harms of conservative, pharmacological, and surgical management options for women with bladder outlet obstruction: A systematic review from the European Association of Urology non-neurogenic female LUTS guidelines panel.
79:S437-S438.
2021
-
Management of women with overactive bladder syndrome: A systematic review with meta-analysis of benefits and potential harms of surgical and non-surgical treatment options by the EAU non-neurogenic female LUTS Guidelines panel.
79:S439-S440.
2021
-
P0169 Antibiotic prophylaxis for prevention of infectious complications after shockwave lithotripsy: A systematic review and meta-analysis.
79:s242-s243.
2021
-
P0182 Lessons learned with remote research among older adults during COVID-19, a qualitative reflection.
79:s260-s261.
2021
-
P0306 A systematic review of patients’ values, preferences and expectations for the diagnosis and treatment of male Lower Urinary Tract Symptoms (LUTS).
79:s441.
2021
-
P1141 Practice variation in the management of adult hydroceles: A multinational survey.
79:s1609-s1610.
2021
-
What are the different diagnostic tests for female Bladder Outlet Obstruction (fBOO)? A systematic review from the European Association of Urology non-neurogenic female LUTS Guidelines Panel.
79:S435-S436.
2021
-
European Association of Urology Position Paper on the Prevention of Infectious Complications Following Prostate Biopsy.
79:11-15.
2021
-
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.
78:834-844.
2020
-
An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting.
78:546-569.
2020
-
Baseline Risks of Venous Thromboembolism and Major Bleeding are Crucial in Decision-making on Thromboprophylaxis.
78:369-370.
2020
-
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
77:614-627.
2020
-
Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up.
77:311-317.
2020
-
Response of Primary Renal Cell Carcinoma to Systemic Therapy.
76:852-860.
2019
-
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).
76:790-813.
2019
-
Treatment of Bladder Stones in Adults and Children: A Systematic Review and Meta-analysis on Behalf of the European Association of Urology Urolithiasis Guideline Panel.
76:352-367.
2019
-
Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.
76:18-23.
2019
-
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
75:967-987.
2019
-
Management of Urinary Retention in Patients with Benign Prostatic Obstruction: A Systematic Review and Meta-analysis.
75:788-798.
2019
-
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer.
75:853-860.
2019
-
Benefits of Empiric Nutritional and Medical Therapy for Semen Parameters and Pregnancy and Live Birth Rates in Couples with Idiopathic Infertility: A Systematic Review and Meta-analysis.
75:615-625.
2019
-
Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions.
75:100-110.
2019
-
Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial.
75:300-309.
2019
-
Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel.
74:76-83.
2018
-
Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel.
73:394-405.
2018
-
Key Steps in Conducting Systematic Reviews for Underpinning Clinical Practice Guidelines: Methodology of the European Association of Urology.
73:290-300.
2018
-
Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis.
73:242-251.
2018
-
Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis.
73:236-241.
2018
-
The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review.
73:94-108.
2018
-
Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis by the European Association of Urology Urological Infection Guidelines Panel.
72:865-868.
2017
-
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
72:869-885.
2017
-
Medical Treatment of Nocturia in Men with Lower Urinary Tract Symptoms: Systematic Review by the European Association of Urology Guidelines Panel for Male Lower Urinary Tract Symptoms..
72:757-769.
2017
-
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
72:801-813.
2017
-
Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians’ Health Study.
72:821-827.
2017
-
What are the Benefits and Harms of Ureteroscopy Compared with Shock-wave Lithotripsy in the Treatment of Upper Ureteral Stones? A Systematic Review.
72:772-786.
2017
-
Reply to Philipp Dahm, Vikram Narayan, and Jae Hung Jung's Letter to the Editor re: Richard J. Sylvester, Steven E. Canfield, Thomas B.L. Lam, et al. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree. Eur Urol 2017;71:811–9.
72:e93-e94.
2017
-
Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol. 2017;71:606–17.
72:e59-e60.
2017
-
Tract Sizes in Miniaturized Percutaneous Nephrolithotomy: A Systematic Review from the European Association of Urology Urolithiasis Guidelines Panel.
72:220-235.
2017
-
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
72:250-266.
2017
-
The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
72:84-109.
2017
-
Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree.
71:811-819.
2017
-
Sentinel Node Procedure in Prostate Cancer: A Systematic Review to Assess Diagnostic Accuracy.
71:596-605.
2017
-
Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms..
71:391-402.
2017
-
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
70:1052-1068.
2016
-
Incidence and Remission of Nocturia: A Systematic Review and Meta-analysis.
70:372-381.
2016
-
Long-term Impact of Mode of Delivery on Stress Urinary Incontinence and Urgency Urinary Incontinence: A Systematic Review and Meta-analysis.
70:148-158.
2016
-
Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel.
69:980-983.
2016
-
Reply from Authors re: Tracy L. Rose, Matthew I. Milowsky. A Small Step Toward Improving Salvage Treatment for Metastatic Bladder Cancer — At What Cost? Eur Urol 2016;69:642–44.
69:644-645.
2016
-
Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.
69:634-641.
2016
-
Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma..
69:634-641.
2016
-
The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis.
69:624-633.
2016
-
Re: The Incidence and Relative Risk of Cardiovascular Toxicity in Patients Treated with New Hormonal Agents for Castration-resistant Prostate Cancer.
69:177-178.
2016
-
Words or Wisdom: Re: The Incidence and Relative Risk of Cardiovascular Toxicity in Patients Treated with New Hormonal Agents for Castration-resistant Prostate Cancer..
69:177-178.
2016
-
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction..
67:1099-1109.
2015
-
Systematic Review and Meta-analysis of Candidate Gene Association Studies of Lower Urinary Tract Symptoms in Men.
66:752-768.
2014
-
What Is the Most Bothersome Lower Urinary Tract Symptom? Individual- and Population-level Perspectives for Both Men and Women.
65:1211-1217.
2014
-
The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer.
65:3-6.
2014
-
Comorbidity Status Does Not Independently Predict Survival Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
64:518-519.
2013
-
Immediate Post–Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non–Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review.
64:421-430.
2013
-
Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials.
63:717-723.
2013
-
Cost Effectiveness of Treatment Options for Early Prostate Cancer: Can We Put the Puzzle Pieces Together?.
63:411-412.
2013
-
Does the Imprecise Definition of Overactive Bladder Serve Commercial Rather than Patient Interests?.
61:746-748.
2012
-
Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer.
61:363-369.
2012
-
Reply to YiJun Shen and DingWei Ye's Letter to the Editor re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer. Eur Urol 2012;61:363–9.
61:e4-e5.
2012
-
Non–Risk-Adapted Surveillance in Clinical Stage I Nonseminomatous Germ Cell Tumors: The Princess Margaret Hospital’s Experience.
59:556-562.
2011
-
The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study..
59:629-636.
2011
-
A panel of TMPRSS2:ERG fusion transcript markers for urine-based prostate cancer detection with high specificity and sensitivity..
59:407-414.
2011
-
Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland..
57:488-496.
2010
-
Re: Gunnar Aus, Christopher Chapple, Tomas Hanûs, et al. The European Association of Urology (EAU) Guidelines Methodology: A Critical Evaluation. Eur Urol 2009;56:859–64.
56:e21-e22.
2009
-
Systematic Review and Meta-Analysis of Robotic-Assisted versus Conventional Laparoscopic Pyeloplasty for Patients with Ureteropelvic Junction Obstruction: Effect on Operative Time, Length of Hospital Stay, Postoperative Complications, and Success Rate.
56:848-858.
2009
-
Testosterone and Prostate Cancer: Revisiting Old Paradigms.
56:48-56.
2009
-
Editorial Comment on: Metastin Inhibits Migration and Invasion of Renal Cell Carcinoma with Overexpression of Metastin Receptor.
55:450-451.
2009
-
Lower Plasma Adiponectin Levels Are Associated with Larger Tumor Size and Metastasis in Clear-Cell Carcinoma of the Kidney.
54:866-874.
2008
-
Editorial Comment on: Photodynamic Diagnosis in Urology: State-of-the-Art.
53:1149-1150.
2008
-
12-YEAR EXPERIENCE USING THE DORMIA BASKET FOR THE EXTRACTION OF URETERIC STONES.
9:93-96.
1983
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)